Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Outsourcing-Pharma

09:59 EDT 16th October 2018 | BioPortfolio

Here are the most relevant search results for "Outsourcing-Pharma" found in our extensive news archives from over 250 global news sources.

More Information about Outsourcing-Pharma on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Outsourcing-Pharma for you to read. Along with our medical data and news we also list Outsourcing-Pharma Clinical Trials, which are updated daily. BioPortfolio also has a large database of Outsourcing-Pharma Companies for you to search.

Showing News Articles 1–25 of 478 from Outsourcing-Pharma

Monday 15th October 2018

Almac opens new facility at NC-based campus following increased customer demand

Almac has opened a new 24,000 square foot building at its location in Durham, NC to meet demand driven by the rise in biological investigational products, says CDMO.

Iqvia inks genomics deal to advance discovery of precision meds

Iqvia says its collaboration with Genomics England will help drugmakers and academics draw insights from clinical-genomic datasets â the âfuture of real-world research.â

Novotech acquires specialty CRO to expand services in Asia-Pacific

Novotech has acquired a CRO to further support its customersâ clinical research programs across different phases and countries in Asia-Pacific â an area in which it has 10 partnership agreements providing access to more than 1.4bn people.

Piramal launches integrated platform for CDMO services

The contract development and manufacturing organization (CDMO) Piramal Pharma Solutions has launched its Xcelerate Integrated Solutions platform.

Friday 12th October 2018

Researchers target clinical trial recruitment challenges with online database

The online resource organizes and maps myriad sources of research on clinical trial recruitment to help users identify promising interventions, say report authors.

Thursday 11th October 2018

‘The opportunities for AI to revolutionize the pharmaceutical industry are clear’: Report

Researchers are using artificial intelligence to catalyze drug discovery and preclinical drug development - improving predictive models to guide efficient design and optimizing multi-drug regimens, as two recent examples.

Allergan joins TriNetX for real-time access to real-world data

Allergan joined the TriNetX network to gain access to patient populations, protocol, and site identification through real-world data.

Allergan joins TriNetX for real-time access for real-world data

Allergan joined the TriNetX network to gain access to patient populations, protocol, and site identification through real-world data.

Wednesday 10th October 2018

Patient engagement a resource-intense but de-risking exercise, says NDA Group

Engaging with patients in the early stages of drug development is a âde-riskingâ approach to regulatory approval, says consultant.

BioIVT acquires donor center to bring fresh blood products to European clients

BioIVT has acquired Clinical Trials Laboratory Services, a UK-based donor center, in an aim to provide fresh blood products to clients.

Collaboration accelerates patient enrollment in genetic Parkinson’s study

Centogene and Denali entered a strategic collaboration to identify and recruit patients with a gene mutation to be enrolled in a Parkinsonâs disease study.

Clinical trial transparency: ‘There is no one answer to what must be disclosed’

The FDA recently released a draft guidance address penalties for those not disclosing clinical trial results, as patients, the scientific community, and other stakeholders call for increased transparency.

Tuesday 9th October 2018

Growing need for CRO expertise in early phase research, overall demand seeing stable growth: Report

The outsourced pharmaceutical services industry is getting out of its comfort zone, leveraging resources and partnership and focusing on how to make improvements â as demand continues to increase, says CRO.

Selexis and Hoba collaborate on neuropathy pain treatment

Selexis and Hoba Therapeutics have entered an agreement to advance Hobaâs clinical candidate for the treatment of peripheral neuropathic pain.

Monday 8th October 2018

FDA guidance on clinical trial data disclosure falls short, while noncompliance remains high

The recent FDA guidance ties penalties for not disclosing clinical trial results to formal inspections â falling short of the public expectation that such data should be readily available, says industry expert.

Icon launches technology for adaptive clinical trial design

Icon has launched an integrated technology platform for the design, simulation, and analysis of adaptive clinical trials.

Clarkston and 4G Clinical partner to better clinical trial operations

The companies announced a partnership to integrate 4Gâs technology with Clarkstonâs clinical supply chain services in an aim to enrich clinical trial strategy and operations.

US FDA says compounder used non-sterile wipes during sterile drug production

The US FDA has issued a warning letter to a compounding pharmacy in California, US, after a facility inspection revealed FDCA violations.

Friday 5th October 2018

People on the Move: Outsourcing-Pharma roundup September '18

Metrion has bolstered its drug discovery leadership team, CluePoints has upped its RBM services, and Concept Life Sciences has added to its analytical services division, among other moves this month in the outsourced pharmaceutical services industry.

Thursday 4th October 2018

Evotec signs fourth translational research agreement with Sanofi

Evotec established an agreement with Sanofi to collaborate with academic institutions worldwide on early-stage translational projects.

TriNetX rolling out new analytical tools to enable more independent research

TriNetX is releasing a series of new tools that will enable more people to conduct health research on their own, with access to rich datasets and analytics, says VP.

Almac forms analytical group, increases capacity

Almacâs Sciences Business Unit has combined its capabilities with BioClin to form an analytical group spanning the UK, Europe, and North America.

Wednesday 3rd October 2018

Economic growth in Asia-Pacific drives Premier Research expansion

Premier Research is expanding its presence in the Asia-Pacific region to include South Korea, Singapore, and Taiwan â with greater health care spending and patient access to new drugs driving demand.

CROs ‘combine forces’ to meet demand from biopharma customers

Veristatâs acquisition of Topstone enhances the CROâs capabilities within several areas and boosts its employee count to 300 across six offices.

In a bind? Comprehend releases risk detection and management platform for mid-sized CROs

Comprehend, a clinical intelligence software company, has packaged its clinical trial risk detection and management service offerings to accommodate the needs of mid-sized CROs.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks